2-36849355-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003162.4(STRN):c.*101T>G variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.106 in 1,365,800 control chromosomes in the GnomAD database, including 13,565 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.097 ( 1472 hom., cov: 32)
Exomes 𝑓: 0.11 ( 12093 hom. )
Consequence
STRN
NM_003162.4 3_prime_UTR
NM_003162.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.53
Genes affected
STRN (HGNC:11424): (striatin) Enables armadillo repeat domain binding activity; estrogen receptor binding activity; and protein phosphatase 2A binding activity. Involved in Wnt signaling pathway and negative regulation of cell population proliferation. Located in bicellular tight junction. Part of FAR/SIN/STRIPAK complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 2-36849355-A-C is Benign according to our data. Variant chr2-36849355-A-C is described in ClinVar as [Benign]. Clinvar id is 1271638.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.536 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STRN | NM_003162.4 | c.*101T>G | 3_prime_UTR_variant | 18/18 | ENST00000263918.9 | ||
STRN | XM_005264519.6 | c.*101T>G | 3_prime_UTR_variant | 17/17 | |||
STRN | XM_011533073.3 | c.*101T>G | 3_prime_UTR_variant | 19/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STRN | ENST00000263918.9 | c.*101T>G | 3_prime_UTR_variant | 18/18 | 1 | NM_003162.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0973 AC: 14805AN: 152146Hom.: 1463 Cov.: 32
GnomAD3 genomes
AF:
AC:
14805
AN:
152146
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.107 AC: 129779AN: 1213536Hom.: 12093 Cov.: 16 AF XY: 0.108 AC XY: 65633AN XY: 605070
GnomAD4 exome
AF:
AC:
129779
AN:
1213536
Hom.:
Cov.:
16
AF XY:
AC XY:
65633
AN XY:
605070
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0973 AC: 14822AN: 152264Hom.: 1472 Cov.: 32 AF XY: 0.103 AC XY: 7634AN XY: 74436
GnomAD4 genome
AF:
AC:
14822
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
7634
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1130
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 16, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at